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1. Introduction 
In [ I -3] we demonstrated differences in the regu- 
lation of ornithine decarboxylase (L-ornithine car- 
boxylase, EC 4.1.1.17) activity and putrescine trans- 
port of the undifferentiated and differentiated neuro- 
blastoma ceils, suggesting that alteration of polyamine 
metabolism ay be involved in the differentiation of
mouse neuroblastoma cells. Polyamines (putrescine, 
spermidine and spermine) are ubiquitous organic 
cations occurring abundantly in living organisms 
[4-8]. Although polyanmtes have been implicated in 
proliferative and cancerous growth, their precise 
function(s) in growth regulation remains to be eluci- 
dated. One approach to define the possible role(s) 
of polyamines ingrowth regulation is to identify and 
characterize the specific biochemical reactions involv- 
ing polyamines. 
[3H]Putrescine metabolically labels several low M r 
(rel. tool. wt) proteins in human tymphocytes [9]. 
We have observed [t0] that [l*C]putrescine or [14C]- 
spermidine metabolically labeled an 18 000-M r pro- 
tein in at least 4 different cultured cell lines [10]. 
This metabolic labeling reaction by polyamineg 
appeared to be specific; under the experimental con- 
ditions used, only one protein band with an app.M r of 
18 000 was prominently abeled [10]. Putrescine can 
Abbreviations: NB, undifferentiated neuroblastoma; ND,dif- 
ferentiated neuroblastoma; GABA, 3,-asninobutyric acid; 
Bt~eAMP, ~,O2~-dibutyryl cyclic AMP; IBMX, 3-isobu~q-1- 
methylxanthine; FCS, fetal calf serum 
also be converted to 7-aminobutyric a id in the 
presence of diamine oxidase and aldehyde dehydro- 
genase. This reaction occurs in a number of biological 
systems [11,12] including C-1300 neuroblastoma 
cells maintained in fetal calf serum-containing medium 
[13]. 
The purpose of this study is to compare the metab- 
olism of [laC]putrescine in the NB and ND neuro- 
blastoma cells. We report our findings on the differ- 
ences in the labeling of the 18 000-M r protein and 
the metabolic onversion of [t4C]putrescine into 
[14C]GABA in the NB and ND cells. Our results 
indicated a50-60% decrease of labeling of the 
t 8 000-M r protein of the ND cells when compared to 
that of the NB cells. In addition, there was an 8-10- 
fold increase in the conversion of [14C]putrescine 
into amino [~C]acids via [t4C]GABA. 
2. Materials and methods 
2.1. Chemicals 
The following compounds were purchased: [1,4- 
l*C] putrescine - 2HCI(t 22 mCi/mmol) from Amersham 
(Arlington Heights IL); 7-amino [U-14C]butyric acid 
(203 mCi/mmol) from New England Nuclear, (Boston 
MA); Dulbecco's modified Eagle medium and fetal 
calf serum from Gibco (Grand Island NY);N~,O 2'- 
dibutyryt cyclic AMP, aminoguanidine, phenylmethyl 
sulfonyl fluoride from Sigma Chem. Co. (St Louis 
NO); 34sobuty'l.l-methytxanthine from Aldrich 
Chem. Co. CMilwaukee WI). 
Published by Elsevier/North-Holland Biomedical Press 
00t45793[81/0000-0000/$02.75 © 1981 Federation fEuropean Biochemical Societies 71 
Volume 134, number 1 FEBS LETTERS November 1981 
2.2. Cell culture and differentiation 
Mouse NB-15 neuroblastoma cells were grown as 
monolayer cultures as in [2]. The differentiation of 
neuroblastoma cells was induced by adding 1 mM 
Bt2cAMP and 0.5 mM IBMX to the cell culture 15 h 
after subculture (seeding was at ~1 X 104 cells/cm2). 
Unless otherwise specified, the NB and ND neuro- 
blastoma cells at stationary phase of growth (~4-5 
days after subculture) were used. 
2.3. Metabolic labeling with [ 14C]putrescine of
[ 14C]GABA 
Both the NB and ND cells were washed twice and 
re-incubated in fresh Dulbecco's medium. [ 14C] Putres- 
cine or [14C]GABA was added to the cell culture to a 
designated final concentration. FCS or other agents 
were then added to the appropriate concentrations. 
Cells were incubated at 37°C in a water-jacketed CO2 
incubator (95% air, 5% CO2, 100% humidity) for 20 h. 
At the end of this incubation period, cells were 
washed 3 times with cold phosphate-buffered saline 
(pH 7.2), cells were scraped off the substratum in
0.7 ml Tris-HC1 buffer (20 raM, pH 7.2) containing 
1 mM phenylmethylsulfonyl fluoride. The cell sus- 
pension was then homogenized by sonication at 4°C. 
The cell homogenate hus obtained was used for anal- 
ysis of the incorporation of radioactivity into trich- 
loroacetic acid-insoluble material and for sodium 
dodecylsulfate (SDS)-polyacrylamide g lelectropho- 
resis and fluorography. Protein was assayed by Lowry's 
method [14]. 
2.4. SDS-Polyacrylamide g l electrophoresis 
Cell homogenate which contained 0.5-3.0 mg pro- 
tein/ml was mixed with 1/5 th of its volume of an 
SDS-stop solution containing 12% SDS, 0.5 M Tris- 
HC1 (pH 9.0), 10% fl-mercaptoethanol, 5 mM EDTA, 
25% glycerol and 0.005% pyronin Y and heated at 
100°C for 5 rain. The samples were then subjected 
to SDS-polyacrylamide gradient slab-gel electropho- 
resis (7.5-15% acrylamide) as in [15]. 
Fluorograms were prepared according to [ 16]. 
Fluorograms were scanned with a Schoeffel SD-3000 
spectro-microdensitometer and the peak areas of the 
optical tracings were used as a quantitative measure- 
ment of the amount of radioactivity incorporated. 
3. Results 














Fig.1. The incorporation of  [14C]putrescine into acid-insolu- 
ble material into the NB and ND ceils. Cells were incubated 
with [t4C]putrescine (1 uCi/ml) in fresh Dulbecco's medium 
in the absence or in the presence of 10% FCS for 20 h at 
37°C. Trichloroacetic acid-insoluble counts were determined 
by the filter-disc assay method in [ 20 ]. 
porated into the trichloroacetic a id4nsoluble material 
after incubation of the NB and ND cells with [14C]- 
putrescine for 20 h. Our results demonstrated an
increased incorporation of radioactivity into the ND 
cells both in the absence and presence of 10% fetal 
calf serum. The presence of FCS stimulated the 
amount of radioactivity incorporated into trichloro- 
acetic acid-insoluble material of both the NB and ND 
cells. It should be noted that the increased incorpora- 
tion of radioactivity into the ND cells was not due to 
an increase in the transport or specific activity of 
[14C] putrescine in the ND cells; total cellular uptake 
of radioactivity in the NB cells was actually 50-80% 
higher than that of the ND cells. 
The pattern of incorporation of radioactivity into 
individual protein bands was analyzed by SDS-poly- 
acrylamide gel electrophoresis and fluorography. 
The result of such an experiment is shown in fig.2. In 
the absence of FCS (fig.2B), an 18 000-M r protein 
was identified as the major radioactive band of both 
the NB and ND cells. The absolute amount of radio- 
activity incorporated into the 18 000-M r protein of 
the ND cells was only 60% of that of the NB cells as 
estimated from the densitometric tracings of the fluo- 
rogram. The presence of FCS during the 20 h incuba- 
tion period with [ 14C] putrescine increased the amount 
of radioactivity incorporated into the 18 000-M r pro- 
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the exception of the 18 000-M r protein) in the presence 
of FCS may be attributable to radioactive amino 
acids derived from the [14C]putrescine. 
In this connection, we have carried out experi- 
ments to examine the effects of aminoguanidine on
the incorporation of radioactivity, and to study the 
pattern of radioactivity using [14C] GABA as precur- 
sor for metabolic labeling of NB cells. As shown in 
fig.3 the presence of aminoguanidine, a potent inhib- 
itor of diamine oxidase [17], abolished the incorpora- 
tion of radioactivity into all protein bands except he 
18 000-M r protein. Furthermore, with the exception 
of 18 000-M r band the labeling pattern of the NB 
cells by [14C]putrescine could be duplicated by using 
[14C] GABA as the precursor (fig.3C). Similar results 
were also obtained with the ND ceils (not shown). 
Fig.2. Fluorogram of the radioactively abeled proteins in the 
NB and ND cells exposed to [t4C]putrescine. Both NB and 
ND cells were incubated with ['4C]putrescine (1 uCi/ml) in 
fresh Dulbecco's medium in the presence (A) or the absence 
(B) of 10% FCS. At the end of 20 h incubation, cells were 
harvested and prepared for SDS-polyacrylamide gelelectro- 
phoresis and fluorography as in section 2. Each lane con- 
tained 50 ug protein. 
tein while retaining the difference of the NB and ND 
cells (fig.2A). More importantly, however, was the 
marked stimulation by FCS of the incorporation of 
radioactivity into a variety of protein bands of the 
ND cells. FCS also caused the incorporation of radio- 
activity into various protein bands other than the 
18 000-M r band in the NB cells. However, the inten- 
sity of those bands was significantly less when com- 
pared to that of the ND cells (fig.2A). 
In attempting to gain a better understanding of 
this FCS-dependent incorporation of radioactivity 
from [14C] putrescine into cenular proteins, we noted, 
with the exception of the 18 000-M r protein, the 
radioactive labeling patterns in fig.2A of both the NB 
and ND cells were qualitatively similar to the 
Coomassie blue-stained protein patterns (not shown). 
In view of this consideration, and the observation 
that putrescine can be converted to GABA [11-13] 
which can be further channeled to form amino acids 
via the GABA shunt and Krebs cycle, we reasoned 
that the labeling of the various cellular proteins (with 
A B C 
t/ 
18K > ~-~ 
Fig.3. Effect of aminoguanidine onthe [14C]putrescine 
labeling pattern and the metabolic labeling pattern of 0 
[ ~#C ] GABA: (A ~)  NB ceils were incubated with [ ~*C ]putres- 
cine (1 t~Ci/ml) in fresh Dulbecco's medium plus 10% FCS in 
the absence (A) or in the presence (B) of 2 × 10 -s M amino- 
guanidine for 20 h; (C) ceils were incubated with [14C]GABA 
(0.5 uCi/ml) in fresh Dulbecco's medium plus 10% FCS for 
20 h. 
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We thus concluded that: 
(i) The 18 000-M r protein represented a unique 
polyamine labeled protein; 
(ii) There was enhanced conversion of putrescine to 
GABA and then to various amino acids in the ND 
cells; 
(iii) The FCS-dependent labeling of various cellular 
proteins other than the 18 000-M r band was 
attributable to the presence of radioactive amino 
acids derived from [14C] putrescine. 
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4. Discussion 
These data have identified two specific biochemical 
events associated with polyamine metabolism occur- 
ring in the NB and ND cells, namely: 
(i) Specific labeling of the 18 000-M r protein; and 
(ii) Conversion of putrescine to amino acids via 
GABA. 
Comparative studies of these biochemical events in 
the NB and ND cells showed that the labeling of the 
18 000-M r band was more prominent in the NB cells 
than in the ND cells whereas the conversion of putres- 
cine to amino acids via GABA was more prominent in 
the ND cells than in the NB cells. 
The metabolic labeling of the 18 000-M r protein 
band in cultured cells exposed to [14C] putrescine 
may represent a direct polyamine-conjugation reac- 
tion, presumably catalyzed by cellular transglutaminase 
[9,10]. Alternatively, it is possible that hypusine 
[Ne-(4-amino-2-hydroxybutyl)-lysine], derived from 
spermidine may serve as the radioactive source for 
the specific labeling of this protein [ 18]. The identity 
of the radioactive moiety in the labeled 18 000-M r
protein of NB and ND cells is under investigation. 
The physiological significance of the conversion of 
putrescine to amino acids via GABA is not clear. In 
view of the fact that the ND cells bear a closer resem- 
blance to the mature neuron cells [19], and that 
GABA is an important neurotransmitter, our finding 
that the ND cells had enhanced capacity to convert 
putrescine to amino acids via GABA may represent 
another biochemical index of  differentiation of 
mouse neuroblastoma cells. 
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